SCHEMBL642646

SCHEMBL642646

CC(C)(O)C(=O)OC(C)(C)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
TSHR P16473 1/20 0.50
PPARA Q07869 2/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33
PPARG P37231 1/20 0.31
DGAT1 O75907 1/20 0.31
HMGCR P04035 1/20 0.31
CHRM1 P11229 1/20 0.31
TBXA2R P21731 1/20 0.31
ADRA1A P35348 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23293010 0.81 TSHR (0.38) ALDH1A1TSHRPPARAMEN1CYP1A2
SCHEMBL14879747 0.77 PPARA (0.36) ALDH1A1TSHRPPARAMEN1CYP1A2
SCHEMBL9064823 0.77 TSHR (0.36) ALDH1A1TSHRPPARACYP2D6CYP2C19
SCHEMBL23567953 0.75 TSHR (0.42) ALDH1A1TSHRPPARAMEN1CYP1A2
SCHEMBL362903 0.75 DGAT1 (0.52) ALDH1A1TSHRDGAT1CHRM1
SCHEMBL6863429 0.73 ALDH1A1 (0.43) ALDH1A1TSHRPPARAMEN1CYP1A2
SCHEMBL10127306 0.73 RIPK1 (0.34) ALDH1A1TSHRPPARAMEN1CYP1A2
SCHEMBL4464867 0.72 GAA (0.44) ALDH1A1TSHRPPARAMEN1CYP1A2
SCHEMBL15308350 0.72 ALDH1A1 (0.38) ALDH1A1TSHRDGAT1
Hydrochloric Acid SCHEMBL338771 0.70 GAA (0.42) ALDH1A1TSHRPPARAMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119799-B2 Method for the production of polyisocyanates comprising isocyanurate groups and use therof BASF AKTIENGESELLSCHAFT (DE) 2012-02-21 US claimed
US-9428437-B2 Method for dehydrating alpha-substituted carboxylic acids EVONIK ROEHM GMBH (DE) 2016-08-30 US disclosed
US-20160090344-A1 METHOD FOR DEHYDRATING ALPHA-SUBSTITUTED CARBOXYLIC ACIDS EVONIK ROEHM GMBH (DE) 2016-03-31 US disclosed
US-8119799-B2 Method for the production of polyisocyanates comprising isocyanurate groups and use therof BASF AKTIENGESELLSCHAFT (DE) 2012-02-21 US disclosed
US-7993630-B2 Protection of skin from UV and peroxide BIODERM RESEARCH (US) 2011-08-09 US disclosed
CN-102076864-A Recombinant cells producing 2-hydroxyisobutyric acid EVONIK ROEHM GMBH 2011-05-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160090344-A1 METHOD FOR DEHYDRATING ALPHA-SUBSTITUTED CARBOXYLIC ACIDS ALAD, EBP, HSD17B12 ALDH1A1 122/4885TSHR 4476/4885PPARA 211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.